The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...

Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.

European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...

With the CHMP affirmation, Moderna is on course to get EU approval for its fourth vaccine product and break new ground in ...

Feb 27 (Reuters) - Europe's medicines regulator on Friday recommended approval for Moderna's mCombriax, paving the way for it to become the first combined shot for protecting people aged 50 and older ...

The European Medicines Agency's (EMA) human medicines committee on Friday recommended the approval of a combined coronavirus and seasonal influenza vaccine developed by Moderna for adults aged 50 and ...

While the FDA has flip-flopped on whether to review Moderna’s combination influenza and COVID-19 vaccine, it’s full speed ahead for the mRNA shot in Europe. | While the FDA has flip-flopped on whether ...

A rise in tuberculosis cases in Malaysia triggered social media posts falsely claiming that the bacteria responsible for the disease were deliberately inserted into Pfizer's Comirnaty Covid-19 ...

If the recommendation is accepted by the European Commission, Moderna's mCombriax vaccine will be available for adults 50 and older throughout the European Union.

GSK’s bepirovirsen accepted for regulatory review in Japan as a potential first-in-class treatment for chronic hepatitis B: London, UK Friday, February 27, 2026, 09:00 Hrs [IST] ...